Beneficial effects of kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats.
about
Kininase 1 As a Preclinical Therapeutic Target for Kinin B1 Receptor in Insulin Resistance.Impact of pioglitazone and bradykinin type 1 receptor antagonist on type 2 diabetes in high-fat diet-fed C57BL/6J mice.Localization and Interaction between Kinin B1 Receptor and NADPH Oxidase in the Vascular System of Diabetic Rats.Kinin B1 receptors as a therapeutic target for inflammation.The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.Different metabolic responses induced by long-term interdisciplinary therapy in obese adolescents related to ACE I/D polymorphism.
P2860
Beneficial effects of kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@en
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@nl
type
label
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@en
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@nl
prefLabel
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@en
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@nl
P2093
P2860
P356
P1476
Beneficial effects of kinin B1 ...... in Zucker diabetic fatty rats.
@en
P2093
Adil El Midaoui
Jenny Pena Dias
Réjean Couture
Sébastien Talbot
P2860
P304
P356
10.1139/CJPP-2016-0063
P577
2016-03-05T00:00:00Z